Immune Microenvironment Equipment
-
Manufactured by XILIS, Inc.based in USA
Xilis’ proprietary MicroOrganoSphere (MOS) technology represents a new standard in patient-derived micro-tumor production. From each patient, MOS retains unique patient tissue structure, genetic alterations, gene expression, immune microenvironment and histopathology. Overcoming major limitations of widely used, yet limited, ...
-
based in SOUTH KOREA
OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, HCC, and renal ...
-
Manufactured by NanoStringbased in USA
The GeoMx Cancer Transcriptome Atlas (CTA) is designed for comprehensive profiling of tumor biology, the tumor microenvironment, and the immune response. Profile RNA expression of over 1,800 genes simultaneously with spatial resolution from distinct regions of interest with a single tissue section using the GeoMx Digital Spatial ...
-
based in POLAND
Triple-negative breast cancer (TNBC) is a highly proliferative, rapidly growing, and aggressive form of cancer. TNBC can be further categorized into three types: Type 1 (also known as the “cold” type) is characterized by a tumor with low infiltration of immune cells into the tumor microenvironment; Type 2 is characterized by ...
-
Manufactured by Second Genome Therapeuticsbased in USA
SG-3-06686 binds to CXCR3 receptor on dendritic cells, amplifies the natural ligand which induces a robust immune cell migration to the tumor microenvironment, ultimately resulting in tumor shrinkage. ...
-
Manufactured by Singleron Biotechnologies GmbHbased in GERMANY
GEXSCOPE Single Cell V(D)J Kit enables simultaneous detection of T-cell or B-cell receptor gene expression, together with whole transcriptome expression at single-cell ...
-
Manufactured by NanoStringbased in USA
The GeoMx Immune Pathways Panel is designed for targeted profiling of the tumor, tumor microenvironment, and tumor immune status. Profile up to 96 RNA targets with spatial resolution from a single tissue section using the GeoMx Digital Spatial Profiler ...
-
based in USA
for cancer cell proliferation and survival: the RAS/RAF/MEK/ERK, the PI3K/AKT and the PLK1 pathways. In addition, rigosertib may be a potent immunomodulator via the stimulation of neoantigen expression resulting in attraction of immune cells into the tumor microenvironment and thus making the tumor more susceptible to ...
-
Manufactured by Immune-Onc Therapeutics, Inc.based in USA
Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid leukemia (AML) and chronic myelomonocytic leukemia ...
-
Manufactured by Transgenebased in FRANCE
TG4001 is an innovative therapy capable of combating papillomavirus-induced cancers. The concept behind TG4001 is to teach the immune system to recognise and destroy the cancer cells expressing HPV-16 antigens, specifically E6 and E7 ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you